Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...
Gastric Neuroendocrine Tumors market Forecast. DelveInsight's Gastric Neuroendocrine Tumors Market report offers an in-depth understanding of the epidemiol ...
The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.
On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s (NYSE:MRK) Welireg (belzutifan), an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback